Pcn118 Using Discrete Choice Experiments to Estimate the Marginal Willingness to Pay of Insurance Premium for Stomach Cancer Treatment in Korea

Jo, C; Dh, Cho

doi:10.1016/s1098-3015(10)72207-5

Cited by 1 publication

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For studies comparing WTP for cancer treatment, the lower WTP range ($53-697) was reported by studies that used insurance premium as payment vehicle [34][35][36][65][66][67][68]. The highest WTP value for this category was $62,287 for a hopeful therapy that increased the possibility of long-term survival [54].…”

Section: Wtp Outcomes Reportedmentioning

confidence: 99%

“…The database search identified 5912 records while an additional 4 records were identified through citation tracking. Fifty-four studies (including 12 conference abstracts [32][33][34][35][36][37][38][39][40][41][42][43] and one research letter [44]) were included after screening 3309 abstracts and 86 full-text articles. Thirty-two articles were excluded as per the reasons stated in Fig.…”

Section: Study Selectionmentioning

confidence: 99%

“…Notably, almost all the studies that used OOP as the payment vehicle reported a WTP of at least $10,000 per annum for 1-year survival, with the exception of a study that compared community dwelling older adults ($1975) with advanced cancer patients ($13,746) [48]. Other studies that reported lower WTP ranges for 1-year survival ($3-$21) were those that elicited WTP as an insurance premium to improve survival rate in different types of cancer [34][35][36].…”

Section: Wtp Outcomes Reportedmentioning

confidence: 99%

See 2 more Smart Citations

Willingness-to-pay for cancer treatment and outcome: a systematic review

et al. 2021

View full text Add to dashboard Cite

Background Understanding patient preferences in cancer management is essential for shared decision-making. Patient or societal willingness-to-pay (WTP) for desired outcomes in cancer management represents their preferences and values of these outcomes. Objective The aim of this systematic review is to critically evaluate how current literature has addressed WTP in relation to cancer treatment and achievement of outcomes. Methods Seven databases were searched from inception until 2 March 2021 to include studies with primary data of WTP values for cancer treatments or achievement of outcomes that were elicited using stated preference methods. Results Fifty-four studies were included in this review. All studies were published after year 2000 and more than 90% of the studies were conducted in high-income countries. Sample size of the studies ranged from 35 to 2040, with patient being the most studied population. There was a near even distribution between studies using contingent valuation and discrete choice experiment. Based on the included studies, the highest WTP values were for a quality-adjusted life year (QALY)

show abstract